FindTrial
Sign In

A study to compare Oral Probiotics and Standard Antibiotic Therapy for treating women with Bacterial Vaginosis

Oral Probiotics vs Standard Antibiotic Therapy for Bacterial Vaginosis- A Randomised, Double Blind, Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099623
Enrollment
100
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere

Interventions

Intervention1: PROBIOTIC: ORAL PROBIOTICS will be given once daily for 10 days Control Intervention1: Tab METRONIDAZOLE 400 mg: STANDARD THERAPY OF Tab METRONIDAZOLE 400 mg thrice a day for 7 days

Sponsors

Dr Sakshi Chandak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consenting women in age group of 18-45 years, 2. Presenting with discharge per vaginum

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Women with any other vaginal or cervical pathology like cervical polyp, cervical erosion, carcinoma cervix, etc. 3. Women who have had previous treatment for Bacterial vaginosis 4. Menstruating at the time of examination

Design outcomes

Primary

MeasureTime frame
RECURRENCE OF BACTERIAL VAGINOSIS BY ASSESSING NUGENT SCORE (IF ABOVE SEVEN) OR AMSELS CRITERIA POSITIVETimepoint: After 30 days of giving treatment—

Secondary

MeasureTime frame
1. patients satisfaction by life style questionnaireTimepoint: After 30 days of giving treatment;2. Side effectsTimepoint: After 30 days of giving treatment—

Countries

India

Contacts

Public ContactSakshi Chandak

Datta Meghe Institite of Higher Education And Research(DU)

sanjivaniwanjari@yahoo.com.com9822573624

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026